Nigella sativa, also known as ‘black cumin’, belongs to the family of Ranunculaceae and is mainly used in the form of oil. 1 The main constituent of the Nigella Sativa oil (NSO) is thymoquinone, which represents between 27.8 and 57% of the essential oil. NSO is the subject of studies for its pharmacological properties in various fields such as oncology 2 and allergology. 3 Few case reports of contact dermatitis,4, 5, 6 bullous delayed hypersensitivity and Stevens–Johnson syndrome or toxic epidermal necrosis related to NSO have been published.7, 8 To date, only one case of drug reaction with eosinophilia and systemic symptoms (DRESS), a delayed T‐cell adverse drug reaction, after application of NSO has been reported. 9 We report here a case of DRESS after application of NSO confirmed by positive patch test.
CASE REPORT
A 28‐year‐old woman, with no medical history and no history of allergies, presented with generalized exanthema sparing the face 1 week after application of NSO on the whole tegument including the face once daily. Clinical examination at the admission revealed extensive and infiltrative exanthema associated with oedema of extremities and enlarged lymph nodes. There was no mucosal involvement and no Nikolsky sign. Blood tests showed eosinophilia at 2.89*109/L (N < 0.5*109/l) and atypical lymphocytes. There was no visceral involvement, especially no kidney or liver failure. Epstein–Barr virus (EBV), cytomegalovirus (CMV), parvovirus B19, human herpes virus 6 (HHV6), human herpes virus 8 (HHV8) blood PCR viral load remained negative. Histologic analysis of a 4‐mm lesional skin biopsy of the upper thigh showed eosinophilic spongiosis without lichenoid alterations or keratinocyte necrosis, as well as an intense superficial lymphocytes and eosinophils perivascular infiltrate. Direct immunofluorescence was negative. The Kardaun severity score was evaluated at 5 (skin rash suggesting DRESS +1, skin rash affecting >50% of the body surface area + 1, eosinophilia >1.5 g/L + 2, atypical lymphocytes +1, enlarged lymph nodes +1, no fever ‐1) 10 suggesting the diagnosis of DRESS induced by NSO. Systemic corticosteroids (40 mg/day prednisone) were initiated and resulted in complete regression of the exanthema within 1 month. Six months later epicutaneous patch test were performed with NSO brought by the patient and tested ‘as is’ with Finn Chamber (Epitest, Antony, France) (concentration of Nigella sativa: 0.001%): at day(D) 3 (after 2 days of occlusion) reading was positive with infiltration and a discrete papule (+ according to International Contact Dermatitis Research Group, ICDRG, criteria; as seen in Figure 1). Patch test with the same oil performed on three team members' as negative controls (with their agreement) remained negative.
FIGURE 1.
Generalized, infiltrated, pruritic maculopapular exanthema (A); positive epicutaneous patch test with black cumin oil brought by the patient (concentration of Nigella sativa: 0.001%) at day(D) 3 reading (B)
DISCUSSION
We report here a case of DRESS syndrome after application of NSO confirming the associated risk of severe cutaneous adverse reactions (SCARS). The attributed therapeutic properties, the consumers' attraction to ‘biologic’ or natural products and the easy access as over‐the‐counter product may lead to underestimation of the potential side effects and increased use of NSO in the future. 11 Therefore, clinicians should be aware of SCARS related to NSO and inform their patients about this risk. Moreover, SCARS related to NSO should be reported to the pharmacovigilance network.
FUNDING SOURCES
This article has no funding source.
CONFLICTS OF INTEREST
The authors have no conflict of interest to declare.
ACKNOWLEDGEMENT
The patients in this manuscript have given written informed consent to publication of their case details including images.
Fargeas M, Calugareanu A, Ben‐Said B. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after topical use of Nigella sativa (black cumin) oil. Contact Dermatitis. 2022;87(2):203‐204. doi: 10.1111/cod.14127
REFERENCES
- 1. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res. 2000;14(5):323‐328. [DOI] [PubMed] [Google Scholar]
- 2. Ansary J, Giampieri F, Forbes‐Hernandez TY, et al. Nutritional value and preventive role of Nigella sativa L. and its main component thymoquinone in cancer: an evidenced‐based review of preclinical and clinical studies. Molecules. 2021;26(8):2108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299‐305. [DOI] [PubMed] [Google Scholar]
- 4. Nosbaum A, Ben Said B, Halpern S‐J, Nicolas J‐F, Bérard F. Systemic allergic contact dermatitis to black cumin essential oil expressing as generalized erythema multiforme. Eur J Dermatol. 2011;21(3):447‐448. [DOI] [PubMed] [Google Scholar]
- 5. Steinmann A, Schätzle M, Agathos M, Breit R. Allergic contact dermatitis from black cumin (Nigella sativa) oil after topical use. Contact Dermatitis. 1997;36(5):268‐269. [DOI] [PubMed] [Google Scholar]
- 6. Zedlitz S, Kaufmann R, Boehncke W‐H. Allergic contact dermatitis from black cumin (Nigella sativa) oil‐containing ointment. Contact Dermatitis. 2002;46(3):188. [DOI] [PubMed] [Google Scholar]
- 7. Bonhomme A, Poreaux C, Jouen F, Schmutz J‐L, Gillet P, Barbaud A. Bullous drug eruption to Nigella sativa oil: consideration of the use of a herbal medicine ‐ clinical report and review of the literature. J Eur Acad Dermatol Venereol. 2017;31(4):e217‐e219. [DOI] [PubMed] [Google Scholar]
- 8. Gaudin O, Toukal F, Hua C, et al. Association between severe acute contact dermatitis due to Nigella sativa oil and epidermal apoptosis. JAMA Dermatol. 2018;154(9):1062‐1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Lellig E, Pinault AL, Vaillant A, Yéléhé M, Beurrier M, Bursztejn AC. Syndrome d'hypersensibilité médicamenteuse (DRESS) secondaire à l'application d'huile de nigelle [Internet]. EM‐Consulte. [cited 2022 Feb 6] Available from: https://www.em-consulte.com/article/1409267/syndrome-d-hypersensibilite-medicamenteuse-dress-s
- 10. Kardaun SH, Sidoroff A, Valeyrie‐Allanore L, et al. Variability in the clinical pattern of cutaneous side‐effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609‐611. [DOI] [PubMed] [Google Scholar]
- 11. Butt MS, Sultan MT. Nigella sativa: Reduces the risk of various maladies. Crit Rev Food Sci Nutr. 2010;50(7):654‐665. [DOI] [PubMed] [Google Scholar]